Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Cash from Investing Activities (2020 - 2025)

Vivos Therapeutics has reported Cash from Investing Activities over the past 6 years, most recently at -$1.6 million for Q4 2025.

  • Quarterly Cash from Investing Activities fell 858.18% to -$1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.5 million through Dec 2025, down 1225.0% year-over-year, with the annual reading at -$7.5 million for FY2025, 1225.0% down from the prior year.
  • Cash from Investing Activities was -$1.6 million for Q4 2025 at Vivos Therapeutics, down from $83000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $83000.0 in Q3 2025 and troughed at -$5.9 million in Q2 2025.
  • The 5-year median for Cash from Investing Activities is -$196000.0 (2022), against an average of -$623950.0.
  • Year-over-year, Cash from Investing Activities crashed 19533.47% in 2021 and then skyrocketed 143.23% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$382000.0 in 2021, then surged by 47.64% to -$200000.0 in 2022, then rose by 17.5% to -$165000.0 in 2023, then changed by 0.0% to -$165000.0 in 2024, then crashed by 858.18% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Cash from Investing Activities are -$1.6 million (Q4 2025), $83000.0 (Q3 2025), and -$5.9 million (Q2 2025).